慢性病管理市场：按疾病类型、按服务类型、按交付方式、按最终用户、按地区

2025年全球慢性病管理市场规模估计为64.9亿美元，预计到2032年将达到158.5亿美元，2025年至2032年的复合年增长率为13.6%。

数字。慢性病管理市占率（按地区划分）（2025年）

糖尿病、癌症、心血管疾病 (CVD)、慢性阻塞性肺病(COPD) 和气喘等慢性疾病是需要持续医疗照护并限制日常生活的长期健康状况。这些通常可以透过改变生活方式来预防，例如避免吸烟和保持健康的体重。然而，繁忙的日程和紧张的生活使得控制这些症状变得困难。这推动了对更好的慢性病管理技术的需求。远端患者监护方面的各种技术进步以及政府改善医疗保健基础设施的倡议不断增加，可能会在不久的将来推动市场成长。

市场动态：

全球慢性病管理市场的成长受到多种因素的推动，例如患有多种慢性病的老龄人口不断增加、肥胖和饮食习惯改变导致糖尿病和心血管疾病等文明病的患病率上升、对早期发现和疾病管理益处的认识不断提高、数字健康解决方案的技术进步以及各国政府和私人组织为控制不断增长的医疗支出所做的努力。然而，对资料隐私的担忧、部署远端监控设备和服务的高成本以及开发中国家熟练医疗专业人员的短缺可能会阻碍更快速的普及。用于管理多种病理的整合平台的开发、人工智慧和可穿戴技术作用的不断扩大以及对个性化护理的日益关注为市场上的公司提供了丰厚的增长机会。

本研究的主要特点

本报告对全球慢性病管理市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

全球慢性病管理市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。

研究涉及的主要企业包括 IBM、Cerner Corporation、Epic Systems、McKesson Corporation、Athenahealth、Healthagen、Allscripts、Optum（UnitedHealth Group 的一部分）、Conifer Health Solutions、NXGN Management、Phytel、I2I Population Health 和 Healthwise。

本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球慢性疾病管理市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过用于分析全球慢性病管理市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 收购与合作场景
• 资金筹措与投资
• PEST分析
• 波特分析

4. 全球慢性病管理市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 全球慢性病管理市场（依疾病类型），2021-2032 年

• 心血管疾病
• 糖尿病
• 呼吸系统疾病
• 癌症
• 慢性肾臟病
• 其他的

6. 全球慢性病管理市场（依服务类型），2021-2032 年

• 疾病管理计划
• 远端患者监护
• 远端医疗服务
• 其他的

7. 全球慢性病管理市场（以交付方式），2021-2032 年

• 本地
• 基于网路
• 云端基础

8. 全球慢性病管理市场（依最终使用者划分），2021 年至 2032 年

• 医院
• 专科诊所
• 居家照护环境
• 其他的

9. 全球慢性病管理市场（按地区划分），2021-2032 年

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • UnitedHealth Group
  • CVS Health
  • Cigna
  • Anthem, Inc.
  • Aetna（a CVS Health company）
  • Mayo Clinic
  • Kaiser Permanente
  • Humana Inc.
  • Teladoc Health, Inc.
  • McKesson Corporation
  • Cerner Corporation
  • Epic Systems Corporation
  • Medtronic
  • Abbott Laboratories
  • Novartis AG
  • Roche Holding AG
  • Bristol-Myers Squibb
  • Johns Hopkins Medicine
  • GE Healthcare
  • Philips Healthcare

第 11 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第十二章参考文献与调查方法

• 参考
• 调查方法

Global Chronic Disease Management Market is estimated to be valued at USD 6.49 Bn in 2025 and is expected to reach USD 15.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.

Figure. Chronic Disease Management Market Share (%), By Region 2025

Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.

Market Dynamics:

Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market

Detailed Segmentation-

• Disease Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Cancer
  • Chronic Kidney Disease
  • Others (Arthritis, etc.)
• Service Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Disease Management Programs
  • Remote Patient Monitoring
  • Telehealth Services
  • Others (Diagnostic Services, etc.)
• Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
  • On-premise
  • Web-based
  • Cloud-based
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Others (Pharmaceutical Companies, etc.)
• Regional Insights (Revenue, USD Bn 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • UnitedHealth Group
  • CVS Health
  • Cigna
  • Anthem, Inc.
  • Aetna (a CVS Health company)
  • Mayo Clinic
  • Kaiser Permanente
  • Humana Inc.
  • Teladoc Health, Inc.
  • McKesson Corporation
  • Cerner Corporation
  • Epic Systems Corporation
  • Medtronic
  • Abbott Laboratories
  • Novartis AG
  • Roche Holding AG
  • Bristol-Myers Squibb
  • Johns Hopkins Medicine
  • GE Healthcare
  • Philips Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Service Type
  • Market Snapshot, By Delivery Mode
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Chronic Disease Management Market, By Disease Type, 2021 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Respiratory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Kidney Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Chronic Disease Management Market, By Service Type, 2021 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Disease Management Programs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Remote Patient Monitoring
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Telehealth Services
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Chronic Disease Management Market, By Delivery Mode, 2021 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• On-premise
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Web-based
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cloud-based
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Chronic Disease Management Market, By End User, 2021 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Chronic Disease Management Market, By Region, 2021 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • UnitedHealth Group
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CVS Health
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cigna
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Anthem, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Aetna (a CVS Health company)
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mayo Clinic
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kaiser Permanente
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Humana Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teladoc Health, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • McKesson Corporation
  • Cerner Corporation
  • Epic Systems Corporation
  • Medtronic
  • Abbott Laboratories
  • Novartis AG
  • Roche Holding AG
  • Bristol-Myers Squibb
  • Johns Hopkins Medicine
  • GE Healthcare
  • Philips Healthcare

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact